OBIO
OBIO
NASDAQ · Health Care

Orchestra Biomed Holdings In

$3.91
+0.20 (+5.39%)
As of Feb 8, 2:04 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 68.62M 71.19M 67.09M
Net Income 10.58M 11.27M 10.19M
EPS
Profit Margin 15.4% 15.8% 15.2%
Rev Growth -5.8% -4.6% -3.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 31.41M 32.93M 31.53M
Total Equity 72.86M 78.63M 70.41M
D/E Ratio 0.43 0.42 0.45
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 14.36M 13.60M 15.28M
Free Cash Flow 6.20M 6.53M 6.19M